+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Protein Engineering Market by Type, Technology Platform, Protein Type, Host Organism, Application, End User - Global Forecast 2026-2032- Product Image
Protein Engineering Market by Type, Technology Platform, Protein Type, Host Organism, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Protein Engineering Market by Type, Technology Platform, Protein Type, Host Organism, Application, End User - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532963
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Protein Engineering Market is projected to reach USD 4.98 Billion in 2026. It is expected to continue growing at a CAGR of 11.08%, reaching USD 9.51 Billion by 2032.

Protein engineering is moving from a specialized research capability to a core platform for biopharmaceuticals, industrial biotechnology, diagnostics, agriculture, food technology, and sustainable materials. The field combines rational design, directed evolution, synthetic biology, and computational modeling to create proteins with improved affinity, stability, specificity, expression yield, and manufacturability.

Demand is supported by established evidence across approved recombinant therapeutics, monoclonal antibodies, enzymes, vaccines, and diagnostic reagents. As organizations seek faster discovery cycles and more resilient biomanufacturing, protein engineering is increasingly tied to artificial intelligence, automation, high-throughput screening, structural biology, and quality-by-design strategies.

Transformative Shifts in the Protein Engineering Landscape

The protein engineering landscape is being reshaped by high-throughput DNA synthesis, next-generation sequencing, automated liquid handling, microfluidics, and cell-free expression systems. These tools allow teams to test larger variant libraries and shorten the design-build-test-learn cycle while improving reproducibility.

Commercial priorities are also shifting. Biopharma teams are engineering antibodies, enzymes, cytokines, fusion proteins, and gene-editing components for better safety, potency, half-life, and durability, while industrial users are adopting engineered enzymes to lower energy use, reduce solvent dependence, improve process selectivity, and support circular manufacturing models.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is now a major accelerator for structure prediction, sequence optimization, de novo protein design, and developability assessment. DeepMind and EMBL-EBI’s AlphaFold Protein Structure Database has made more than 200 million predicted protein structures available, strengthening global access to structural biology resources and supporting faster hypothesis generation.

The impact is cumulative rather than standalone: AI improves protein modeling and variant prioritization, but wet-lab validation, biophysical characterization, immunogenicity evaluation, toxicity assessment, and regulatory documentation remain essential. Leaders are integrating machine learning with validated datasets, laboratory automation, and governance controls to reduce failed experiments and improve translation from in silico design to manufacturable products.

Key Regional Insights

North America remains a leading region for protein engineering due to strong U.S. and Canadian biopharma ecosystems, university spinouts, venture funding, FDA experience, NIH-supported biomedical research, and advanced contract development and manufacturing capacity. Europe benefits from EMA-aligned regulatory depth, public research funding, established pharmaceutical clusters, and translational science networks across Germany, the United Kingdom, France, Italy, and Spain.

Asia-Pacific is expanding through China’s biotech scale-up, India’s biologics and vaccine manufacturing base, Japan’s precision science infrastructure, South Korea’s biologics CDMO strength, and Australia’s translational research networks. Latin America is led by Brazil and Mexico in public health manufacturing, clinical demand, and regional supply-chain integration. The Middle East, especially Gulf economies, is investing in healthcare localization, genomics, and precision medicine infrastructure, while Africa is building vaccine and biologics capacity through public-private initiatives supported by international health agencies and regional manufacturing programs.

Key Group Insights

ASEAN markets are gaining relevance as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines expand biomedical research, clinical infrastructure, biotechnology incentives, and manufacturing capabilities. The GCC is using national healthcare and economic diversification strategies to attract biologics production, precision medicine investment, genomic programs, and regional life science partnerships.

The European Union provides a large regulated environment supported by Horizon Europe funding, EMA guidance, cross-border research networks, and harmonized quality standards. BRICS countries contribute scale in manufacturing, patient populations, clinical research, and public-sector biotechnology. G7 economies remain central to advanced discovery, intellectual property creation, regulatory science, and high-value biomanufacturing, while NATO countries increasingly view biosecurity, supply-chain resilience, pathogen preparedness, and dual-use risk management as strategic priorities for protein engineering and synthetic biology.

Key Country Insights

The United States leads through NIH-funded science, FDA regulatory maturity, venture-backed biotechnology, clinical trial density, and deep biomanufacturing capacity, while Canada offers strong academic clusters, biologics expertise, and translational research programs. Mexico supports regional manufacturing integration and nearshore supply-chain opportunities, and Brazil contributes public vaccine institutions, biopharma demand, clinical research capacity, and long-standing public health manufacturing experience.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine pharmaceutical manufacturing, academic excellence, clinical networks, regulatory experience, and skilled bioprocessing talent, while Russia maintains domestic biotechnology capabilities and scientific infrastructure. China is scaling discovery and manufacturing under NMPA oversight; India is a major vaccine, biosimilar, and biologics producer; Japan emphasizes quality, precision regulation, and advanced life sciences; Australia supports translational medicine and clinical development; and South Korea is a global biologics CDMO and biosimilars hub supported by government-backed biomanufacturing ambitions.

Actionable Recommendations for Industry Leaders

Industry leaders should connect AI-enabled protein design with automated experimentation, robust assay design, early developability screening, and manufacturability assessment. Investment should prioritize validated datasets, protein expression platforms, analytical characterization, formulation science, and scalable purification processes rather than isolated algorithmic tools.

Organizations should also strengthen regulatory readiness, intellectual property strategy, supplier redundancy, cybersecurity, and biosecurity oversight. Partnerships with academic laboratories, CDMOs, cloud laboratories, standards bodies, and regional innovation agencies can accelerate access to talent, infrastructure, specialized assays, and market-specific compliance knowledge.

Research Methodology

This executive summary is grounded in publicly available and verifiable sources, including regulatory agency materials, peer-reviewed scientific literature, patent landscapes, clinical trial registries, public funding announcements, and recognized institutional databases such as FDA, EMA, NIH, WHO, OECD, WIPO, ClinicalTrials.gov, and EMBL-EBI resources.

Insights were triangulated across scientific, commercial, regulatory, and regional indicators. Claims were framed conservatively to avoid unsupported market sizing, market share, or forecasting, and qualitative conclusions were derived from observable technology adoption, approved biologics activity, manufacturing investment, public research programs, and documented advances in computational protein science.

Conclusion

Protein engineering is becoming a strategic foundation for next-generation therapeutics, sustainable biomanufacturing, advanced diagnostics, food system innovation, and resilient health systems. The combination of AI, automation, synthetic biology, structural biology, and validated wet-lab workflows is expanding what organizations can design, test, optimize, and manufacture.

Success will depend on disciplined execution: high-quality data, experimentally confirmed performance, scalable production, regulatory alignment, biosecurity governance, and responsible innovation. Organizations that integrate these capabilities early will be better positioned to capture value across biopharma, industrial enzymes, food systems, precision medicine, and sustainable biotechnology.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Protein Engineering Market, by Type
7.1. Enzyme Engineering
7.1.1. Industrial Enzymes
7.1.2. Medical Enzymes
7.1.3. Diagnostic Enzymes
7.2. Antibody Engineering
7.2.1. Monoclonal
7.2.2. Polyclonal
7.3. Protein Design
7.3.1. De novo Protein Design
7.3.2. Rational Protein Design
7.4. Protein Optimization
7.5. Protein Modification
7.5.1. Glycoengineering
7.5.2. PEGylation
8. Protein Engineering Market, by Technology Platform
8.1. Directed Evolution
8.1.1. DNA Shuffling
8.1.2. Error Prone Pcr
8.2. Gene Synthesis
8.2.1. Gene Fragment Synthesis
8.2.2. Synthetic Gene Assembly
8.3. Site Directed Mutagenesis
8.3.1. Random Mutagenesis
8.3.2. Rational Mutagenesis
9. Protein Engineering Market, by Protein Type
9.1. Insulin
9.2. Monoclonal Antibodies
9.3. Vaccines
9.4. Enzymes
9.5. Hormones
9.6. Cytokines
10. Protein Engineering Market, by Host Organism
10.1. Prokaryotic Systems
10.2. Eukaryotic Systems
10.3. Synthetic Hosts
11. Protein Engineering Market, by Application
11.1. Agricultural Biotechnology
11.1.1. Crop Improvement
11.1.2. Pest Resistance
11.2. Industrial Enzyme Engineering
11.2.1. Biofuels
11.2.2. Detergents
11.3. Therapeutic Protein Development
11.3.1. Monoclonal Antibodies
11.3.2. Vaccines
12. Protein Engineering Market, by End User
12.1. Academic & Research Institutes
12.2. Biotechnology Companies
12.3. Contract Research Organizations
12.4. Pharmaceutical Companies
13. Asia-Pacific Protein Engineering Market
14. North America Protein Engineering Market
15. Latin America Protein Engineering Market
16. Europe Protein Engineering Market
17. Middle East Protein Engineering Market
18. Africa Protein Engineering Market
19. ASEAN Protein Engineering Market
20. GCC Protein Engineering Market
21. European Union Protein Engineering Market
22. BRICS Protein Engineering Market
23. G7 Protein Engineering Market
24. NATO Protein Engineering Market
25. United States Protein Engineering Market
26. Canada Protein Engineering Market
27. Mexico Protein Engineering Market
28. Brazil Protein Engineering Market
29. United Kingdom Protein Engineering Market
30. Germany Protein Engineering Market
31. France Protein Engineering Market
32. Russia Protein Engineering Market
33. Italy Protein Engineering Market
34. Spain Protein Engineering Market
35. China Protein Engineering Market
36. India Protein Engineering Market
37. Japan Protein Engineering Market
38. Australia Protein Engineering Market
39. South Korea Protein Engineering Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Absci Corp
41.2. Abzena Ltd
41.3. Adimab LLC
41.4. Agilent Technologies Inc
41.5. Amgen Inc
41.6. Arzeda Corp
41.7. BigHat Biosciences Inc
41.8. Bio-Rad Laboratories Inc
41.9. Bruker Corporation
41.10. Charles River Laboratories International Inc
41.11. Codexis Inc
41.12. Danaher Corporation
41.13. Evotec SE
41.14. Genentech Inc
41.15. Generate Biomedicines Inc
41.16. GenScript Biotech Corporation
41.17. Ginkgo Bioworks Inc
41.18. Lonza Group Ltd
41.19. Merck KGaA
41.20. Novo Nordisk A/S
41.21. Nuclera Nucleics Ltd
41.22. Profluent Bio Inc
41.23. ProteinQure Inc
41.24. Sino Biological Inc
41.25. Sutro Biopharma Inc
41.26. Thermo Fisher Scientific Inc
41.27. Twist Bioscience Corp
41.28. Waters Corp
41.29. WuXi AppTec Co Ltd
41.30. Zymeworks Inc
List of Figures
FIGURE 1. GLOBAL PROTEIN ENGINEERING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PROTEIN ENGINEERING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PROTEIN ENGINEERING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PROTEIN ENGINEERING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PROTEIN ENGINEERING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL PROTEIN ENGINEERING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. GCC PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. GCC PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. G7 PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. G7 PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. NATO PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. NATO PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CANADA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. MEXICO PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. BRAZIL PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. UNITED KINGDOM PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. GERMANY PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. ITALY PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. SPAIN PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CHINA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. INDIA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. JAPAN PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. AUSTRALIA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SOUTH KOREA PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PROTEIN ENGINEERING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PROTEIN ENGINEERING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL PROTEIN ENGINEERING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INDUSTRIAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INDUSTRIAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INDUSTRIAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MEDICAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MEDICAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MEDICAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIAGNOSTIC ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIAGNOSTIC ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIAGNOSTIC ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIBODY ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTIBODY ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTIBODY ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MONOCLONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MONOCLONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MONOCLONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL POLYCLONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL POLYCLONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL POLYCLONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PROTEIN DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PROTEIN DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PROTEIN DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DE NOVO PROTEIN DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DE NOVO PROTEIN DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DE NOVO PROTEIN DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RATIONAL PROTEIN DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RATIONAL PROTEIN DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RATIONAL PROTEIN DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PROTEIN OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PROTEIN OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PROTEIN OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PROTEIN MODIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PROTEIN MODIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PROTEIN MODIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GLYCOENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GLYCOENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GLYCOENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PEGYLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PEGYLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PEGYLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DNA SHUFFLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DNA SHUFFLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DNA SHUFFLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ERROR PRONE PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ERROR PRONE PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ERROR PRONE PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENE FRAGMENT SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENE FRAGMENT SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENE FRAGMENT SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC GENE ASSEMBLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC GENE ASSEMBLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SYNTHETIC GENE ASSEMBLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SITE DIRECTED MUTAGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SITE DIRECTED MUTAGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SITE DIRECTED MUTAGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RANDOM MUTAGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RANDOM MUTAGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RANDOM MUTAGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RATIONAL MUTAGENESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RATIONAL MUTAGENESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RATIONAL MUTAGENESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL INSULIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL INSULIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INSULIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CYTOKINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CYTOKINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CYTOKINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PROKARYOTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PROKARYOTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PROKARYOTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL EUKARYOTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL EUKARYOTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL EUKARYOTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL SYNTHETIC HOSTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL SYNTHETIC HOSTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL SYNTHETIC HOSTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CROP IMPROVEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CROP IMPROVEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CROP IMPROVEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PEST RESISTANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PEST RESISTANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PEST RESISTANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL INDUSTRIAL ENZYME ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL INDUSTRIAL ENZYME ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL INDUSTRIAL ENZYME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIOFUELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BIOFUELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BIOFUELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DETERGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DETERGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DETERGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL THERAPEUTIC PROTEIN DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL THERAPEUTIC PROTEIN DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL THERAPEUTIC PROTEIN DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 201. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 203. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 204. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 205. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 206. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 207. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 208. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 209. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 210. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 212. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 215. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 216. EUROPE PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 236. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 237. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 238. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 239. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 240. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 241. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 242. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 243. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 244. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 245. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 246. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 248. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 249. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 250. AFRICA PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 253. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 254. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 255. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 256. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 257. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 258. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 259. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 260. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 261. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 262. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 263. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 266. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 267. ASEAN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. GCC PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 269. GCC PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 270. GCC PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 271. GCC PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 272. GCC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 273. GCC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 274. GCC PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 275. GCC PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 276. GCC PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 277. GCC PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 278. GCC PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 279. GCC PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 280. GCC PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 281. GCC PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 282. GCC PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 283. GCC PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 284. GCC PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. BRICS PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 303. BRICS PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 304. BRICS PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 305. BRICS PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 306. BRICS PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 307. BRICS PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 308. BRICS PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 309. BRICS PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 310. BRICS PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 311. BRICS PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 312. BRICS PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 313. BRICS PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 314. BRICS PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. BRICS PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 316. BRICS PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 317. BRICS PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 318. BRICS PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 319. G7 PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 320. G7 PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 321. G7 PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 322. G7 PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 323. G7 PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 324. G7 PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 325. G7 PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 326. G7 PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 327. G7 PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 328. G7 PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 329. G7 PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 330. G7 PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 331. G7 PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 332. G7 PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 333. G7 PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 334. G7 PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 335. G7 PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 336. NATO PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 337. NATO PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 338. NATO PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 339. NATO PROTEIN ENGINEERING MARKET SIZE, BY ANTIBODY ENGINEERING, 2018-2032 (USD MILLION)
TABLE 340. NATO PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN DESIGN, 2018-2032 (USD MILLION)
TABLE 341. NATO PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN MODIFICATION, 2018-2032 (USD MILLION)
TABLE 342. NATO PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2032 (USD MILLION)
TABLE 343. NATO PROTEIN ENGINEERING MARKET SIZE, BY DIRECTED EVOLUTION, 2018-2032 (USD MILLION)
TABLE 344. NATO PROTEIN ENGINEERING MARKET SIZE, BY GENE SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 345. NATO PROTEIN ENGINEERING MARKET SIZE, BY SITE DIRECTED MUTAGENESIS, 2018-2032 (USD MILLION)
TABLE 346. NATO PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
TABLE 347. NATO PROTEIN ENGINEERING MARKET SIZE, BY HOST ORGANISM, 2018-2032 (USD MILLION)
TABLE 348. NATO PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 349. NATO PROTEIN ENGINEERING MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 350. NATO PROTEIN ENGINEERING MARKET SIZE, BY INDUSTRIAL ENZYME ENGINEERING, 2018-2032 (USD MILLION)
TABLE 351. NATO PROTEIN ENGINEERING MARKET SIZE, BY THERAPEUTIC PROTEIN DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 352. NATO PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 353. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 354. UNITED STATES PROTEIN ENGINEERING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 355. UNITED STATES PROTEIN ENGIN

Companies Mentioned

The companies featured in this Protein Engineering market report include:
  • Absci Corp
  • Abzena Ltd
  • Adimab LLC
  • Agilent Technologies Inc
  • Amgen Inc
  • Arzeda Corp
  • BigHat Biosciences Inc
  • Bio-Rad Laboratories Inc
  • Bruker Corporation
  • Charles River Laboratories International Inc
  • Codexis Inc
  • Danaher Corporation
  • Evotec SE
  • Genentech Inc
  • Generate Biomedicines Inc
  • GenScript Biotech Corporation
  • Ginkgo Bioworks Inc
  • Lonza Group Ltd
  • Merck KGaA
  • Novo Nordisk A/S
  • Nuclera Nucleics Ltd
  • Profluent Bio Inc
  • ProteinQure Inc
  • Sino Biological Inc
  • Sutro Biopharma Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp
  • Waters Corp
  • WuXi AppTec Co Ltd
  • Zymeworks Inc

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.98 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.51 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Lab Automation in Protein Engineering Market - Global Forecast 2026-2032 - Product Image

Lab Automation in Protein Engineering Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Protein Engineering - Global Strategic Business Report - Product Image

Protein Engineering - Global Strategic Business Report

  • Report
  • 351 Pages
  • Global
From
Protein Engineering: Market Share, and Growth Analysis by Product Type (Recombinant Proteins, Monoclonal Antibodies, Enzymes), Application, End User, Technology - Product Image

Protein Engineering: Market Share, and Growth Analysis by Product Type (Recombinant Proteins, Monoclonal Antibodies, Enzymes), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Protein Engineering Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Protein Engineering Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 91 Pages
  • Global
From
Protein Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Protein Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From

About the Protein Engineering Market

Protein engineering is a field of biotechnology that involves the manipulation of proteins to create new or improved proteins with desired properties. It is closely related to genomics, which is the study of the structure, function, and evolution of genomes. Protein engineering is used to create proteins with specific functions, such as enzymes, antibodies, and hormones. It is also used to modify existing proteins to improve their properties, such as stability, solubility, and activity. Protein engineering is used in a variety of industries, including pharmaceuticals, biotechnology, and food production. It is used to develop new drugs, create new food products, and improve existing products. It is also used in research to study the structure and function of proteins. Companies in the protein engineering market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.